Cargando…
Pathogenesis and Clinical Management of Uterine Serous Carcinoma
Uterine serous carcinoma (USC) is an aggressive variant of endometrial cancer that has not been well characterized. It accounts for less than 10% of all endometrial cancers and 80% of endometrial cancer–related deaths. Currently, staging surgery together with chemotherapy or radiotherapy, especially...
Autores principales: | Zhang, Li, Kwan, Suet Ying, Wong, Kwong Kwok, Soliman, Pamela T., Lu, Karen H., Mok, Samuel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140057/ https://www.ncbi.nlm.nih.gov/pubmed/32183290 http://dx.doi.org/10.3390/cancers12030686 |
Ejemplares similares
-
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression
por: Kwan, Suet-Ying, et al.
Publicado: (2020) -
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype
por: Hu, Wen, et al.
Publicado: (2020) -
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436
por: Hu, Wen, et al.
Publicado: (2021) -
Ryanodine receptor 1-mediated Ca(2+) signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes
por: Zhang, Li, et al.
Publicado: (2022) -
The Continuum of Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary
por: Wong, Kwong-Kwok, et al.
Publicado: (2007)